Daruwala Paul
- SEC CIK
- 0001639144
No open-market purchases or sales filed in the past year.
Current role at each company
- CDTX Cidara Therapeutics, Inc.Chief Operating Officeras of Sep 13, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Daruwala Paul as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 (view filing) | Sep 12 | 1 day | Daruwala PaulChief Operating Officer | SSale | −16.2K | $0.68 | −$11.0K | −6.8%221.1K after | |
| Jan 7, 2022 (view filing) | Jan 5 | 2 days | Daruwala PaulChief Operating Officer | SSale | −5.13K | $1.25 | −$6.42K | −2.7%187.3K after |